✦ LIBER ✦

Studies on the leishmaniases in the Sudan. 1. Epidemic of cutaneous leishmaniasis in Khartoum

✍ Scribed by S.H. El-Safi; W. Peters

Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 661 KB
Volume: 85
Category: Article
ISSN: 0035-9203
DOI: 10.1016/0035-9203(91)90151-n

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epidemic visceral leishmaniasis in south

Epidemic visceral leishmaniasis in southern Sudan: identity and systematic position of the parasites from patients and vectors

✍ R.W. Ashford; J. Seaman; J. Schorscher; F. Pratlong 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 257 KB

Leishmaniasis in tuscany (Italy): VII. S

Leishmaniasis in tuscany (Italy): VII. Studies on the role of the black rat, Rattus rattus, in the epidemiology of visceral leishmaniasis

✍ L. Gradoni; E. Pozio; M. Gramiccia; M. Maroli; S. Bettini 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 499 KB

The effect of ketoconazole and a combina

The effect of ketoconazole and a combination of rifampicin/amphotericin B on cutaneous leishmaniasis in laboratory mice

✍ Louis Weinrauch; Joseph El-On 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Dosimetric studies based on the radiatio

Dosimetric studies based on the radiation-induced bleaching of Sudan red and Sudan blue dyes in organic solutions

✍ N. Souka; Ayad N. Farag 📂 Article 📅 1990 🏛 Elsevier Science ⚖ 536 KB

Studies on canine leishmaniasis control.

Studies on canine leishmaniasis control. 2. Effectiveness of control measures against canine leishmaniasis in the Isle of Elba, Italy

✍ L. Gradoni; M. Gramiccia; F. Mancianti; S. Pieri 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 575 KB

Dose-ranging studies on liposomal amphot

Dose-ranging studies on liposomal amphotericin B (L-AMP-LRC-1) in the treatment of visceral leishmaniasis

✍ P.V. Bodhe; R.N. Kotwani; B.G. Kirodian; A.V. Pathare; A.K. Pandey; C.P. Thakur; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 537 KB

Efficacy and tolerability of liposomal amphotericin B (LAMP-LRC-1; developed in India by the Liposome Clinical Pharmacology Centre, Mumbai, and the Liposome Research Centre, New Delhi) were assessed in 63 patients suffering from visceral leishmaniasis at centres in Mumbai and Pama. Patients were tre